TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30521699

Group type: EXPERIMENTAL
Intervention: Intensive multifactorial risk factor intervention
Number of subjects: 345

Group type: COMPARATOR
Intervention: Standard treatment according to national guidance
Number of subjects: 345
Study: 26991387

Group type: EXPERIMENTAL
Intervention: Autologous cranioplasty
Number of subjects: 64

Group type: COMPARATOR
Intervention: Titanium cranioplasty
Number of subjects: 64
Study: 25919474

Group type: EXPERIMENTAL
Intervention: Tanezumab (10 mg intravenous injection)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Tanezumab (4 infusions of 10 mg at 8-week intervals)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 23682163

Group type: EXPERIMENTAL
Intervention: Low counts of early angiogenic CPCs (CD34(+), CD34(+)CD133(+), ALDH-bright)
Number of subjects: 129
Study: 22017936

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 6785

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 6785
Study: 19343062

Group type: EXPERIMENTAL
Intervention: Bifendate (three times daily for 14 days)
Number of subjects: 18
Study: 16362474

Group type: EXPERIMENTAL
Intervention: Laparoscopic vascular staplers and disposable clip appliers (S/C)
Number of subjects: 100

Group type: COMPARATOR
Intervention: LigaSure Atlas (LIG)
Number of subjects: 100
Study: 15325876

Group type: EXPERIMENTAL
Intervention: TSP/HEPA cleaning method (high-efficiency particulate air vacuum cleaner and tri-sodium phosphate solution)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-TSP/non-HEPA cleaning method (household vacuum cleaner and household detergent)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both methods (TSP/HEPA and non-TSP/non-HEPA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TSP/HEPA method
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Non-TSP/non-HEPA method
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 40
Study: 11174679

Group type: EXPERIMENTAL
Intervention: Mandibular implant-supported overdenture (IOD)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Conventional complete mandibular denture (CD)
Number of subjects: 89
Study: 9436823

Group type: EXPERIMENTAL
Intervention: celiprolol (200 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: celiprolol (800 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: propranolol (160 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: atenolol (50 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: celiprolol (200 mg and 800 mg) with atenolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: propranolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: celiprolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: propranolol and atenolol
Number of subjects: 12
Study: 8493730

Group type: EXPERIMENTAL
Intervention: Gilchrist bandage
Number of subjects: 28

Group type: COMPARATOR
Intervention: Desault bandage
Number of subjects: 28
Study: 3431825

Group type: EXPERIMENTAL
Intervention: +1.00‐D overcorrection
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: +2.00‐D overcorrection
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: +3.00‐D overcorrection
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: +4.00‐D overcorrection
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: +5.00‐D overcorrection
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: +6.00‐D overcorrection
Number of subjects: 5

Group type: COMPARATOR
Intervention: plano overcorrection
Number of subjects: 5
Study: 28870848

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 45
Study: 27470233

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (bolus + 48-hr infusion)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo (identical infusion volume and duration)
Number of subjects: 202
Study: 24552852

Group type: EXPERIMENTAL
Intervention: Online hemodiafiltration
Number of subjects: 405

Group type: COMPARATOR
Intervention: Low-flux hemodialysis
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 405
Study: 23312829

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg per day
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 118
Study: 20826832

Group type: EXPERIMENTAL
Intervention: Low-intensity intervention (mail contact)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: High-intensity intervention (mail plus telephone or personal contact)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 500
Study: 18612159

Group type: EXPERIMENTAL
Intervention: Adenoma presence at first colonoscopy
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Hyperplastic polyp presence at first colonoscopy
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Adenoma prevalence by age
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Co-occurrence of adenomas and hyperplastic polyps
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Distribution of adenomas and hyperplastic polyps
Number of subjects: 695
Study: 16857655

Group type: EXPERIMENTAL
Intervention: Soy protein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Red clover isoflavones
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoflavone products
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoflavones from soy and red clover
Number of subjects: 0
Study: 14521495

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11189975

Group type: EXPERIMENTAL
Intervention: Pulsed Nd:YAG laser irradiation at 1 W and 15 pps for 1 second in 23 teeth (laser-treated group)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group treated without laser irradiation
Number of subjects: 29
Study: 8673750

Group type: EXPERIMENTAL
Intervention: Salt supplement (120 mmol/day of sodium chloride)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 1496946

Group type: EXPERIMENTAL
Intervention: Iron therapy (syrup containing iron, daily for 2 months)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 7046781

Group type: EXPERIMENTAL
Intervention: Inhaled terbutaline
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral terbutaline
Number of subjects: 12
Study: 31648006

Group type: EXPERIMENTAL
Intervention: Strength Training (ST)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Both ST and PT
Number of subjects: 35
Study: 28894068

Group type: EXPERIMENTAL
Intervention: Pre-warming for 30 minutes
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no pre-warming)
Number of subjects: 62
Study: 27346964

Group type: EXPERIMENTAL
Intervention: Transport of samples to the laboratory
Number of subjects: 1505

Group type: EXPERIMENTAL
Intervention: Labelling of samples
Number of subjects: 1505

Group type: EXPERIMENTAL
Intervention: CSF chemistry requests without appropriate number of CSF sample tubes
Number of subjects: 1505
Study: 24393146

Group type: EXPERIMENTAL
Intervention: Strengthen your ankle App
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional instructional booklet
Number of subjects: 0
Study: 19131285

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy
Number of subjects: 0
Study: 15645098

Group type: EXPERIMENTAL
Intervention: Octopirox at 0.2% active delivered in the amphiphile blend
Number of subjects: 30

Group type: COMPARATOR
Intervention: Octopirox at 0.5% in the simple shampoo base
Number of subjects: 30
Study: 11691705

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (5 to 200 mg/day)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 9137191

Group type: EXPERIMENTAL
Intervention: Active ultrasound device
Number of subjects: 0
Study: 7956700

Group type: EXPERIMENTAL
Intervention: Tumor infiltrating lymphocytes (TILs) immunotherapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lymphokine activated killer (LAK) cell therapy
Number of subjects: 10
Study: 3604620

Group type: EXPERIMENTAL
Intervention: Low-viscosity cement
Number of subjects: 16

Group type: COMPARATOR
Intervention: High-viscosity cement
Number of subjects: 16
Study: 11448083

Group type: EXPERIMENTAL
Intervention: Ethanol (0.8 g/kg up to a maximum of 60 g for males, 50 g for females)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Pen computer (PenC) battery
Number of subjects: 47

Group type: COMPARATOR
Intervention: Pencil-and-paper (PP) tests
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Visual analogue scales (VAS)
Number of subjects: 47
Study: 31366522

Group type: EXPERIMENTAL
Intervention: Various antiemetics (ADs) combinations
Number of subjects: 180
Study: 29415060

Group type: EXPERIMENTAL
Intervention: MRI-based fat and muscle quantification
Number of subjects: 36
Study: 26606381

Group type: EXPERIMENTAL
Intervention: S-1 (40 mg/m² twice a day for 28 consecutive days, repeated every 6 weeks)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 32
Study: 24849450

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 µg/kg loading dose and 0.5 µg·kg(‐1)·h(‐1) maintenance dose
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.8 µg·kg(‐1)·h(‐1) maintenance dose
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.2 µg/kg loading dose and 0.2 µg·kg(‐1)·h(‐1) maintenance dose
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group without dexmedetomidine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Group D3 (0.8 µg/kg loading dose and 0.8 µg·kg(‐1)·h(‐1) maintenance dose
Number of subjects: 80
Study: 22929629

Group type: EXPERIMENTAL
Intervention: 25 μg intravaginal Misoprostol
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0.5 mg intracervical Dinoprostone
Number of subjects: 200
Study: 20089970

Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies (CDA1 and CDB1) at a dose of 10 mg/kg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 17292481

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Paroxetine (rescue arm)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Paroxetine and Placebo
Number of subjects: 33
Study: 16202539

Group type: EXPERIMENTAL
Intervention: Family intervention
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention
Number of subjects: 232

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 232
Study: 12117044

Group type: EXPERIMENTAL
Intervention: salmeterol Diskus (50 microg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo Diskus
Number of subjects: 15
Study: 10354248

Group type: EXPERIMENTAL
Intervention: Management of patients with cataract attending a peripheral ophthalmic clinic for day-surgery
Number of subjects: 0
Study: 7669489

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) 200 mg m‐2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dideoxyinosine (ddI) 100 mg m‐2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of ZDV 200 mg m‐2 plus ddI 100 mg m‐2
Number of subjects: 0
Study: 1701541

Group type: EXPERIMENTAL
Intervention: Holter monitoring
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Programmed electrical stimulation (PES)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Exercise testing
Number of subjects: 15
Study: 7379451

Group type: EXPERIMENTAL
Intervention: Activated charcoal (50 gm as a water suspension followed by 4 doses of 17 gm at 12-hr intervals)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Activated charcoal (80 gm/day for 1 or 2 days)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 7
Study: 31411383

Group type: EXPERIMENTAL
Intervention: Orodispersible minitablet (ODMT) 10 x 1 mg dispersed on the tongue
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Orodispersible minitablet (ODMT) 10 x 1 mg swallowed with water
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference product (RP) Renitec, 2 x 5 mg tablets swallowed with water
Number of subjects: 24
Study: 31811007

Group type: EXPERIMENTAL
Intervention: burr hole cover
Number of subjects: 80

Group type: COMPARATOR
Intervention: no burr hole cover
Number of subjects: 80
Study: 27710137

Group type: EXPERIMENTAL
Intervention: Provider-client interaction
Number of subjects: 418
Study: 26531124

Group type: EXPERIMENTAL
Intervention: MemFlex
Number of subjects: 50

Group type: COMPARATOR
Intervention: Psychoeducation (Control)
Number of subjects: 50
Study: 23318707

Group type: EXPERIMENTAL
Intervention: Service user-researcher
Number of subjects: 161

Group type: COMPARATOR
Intervention: Clinician
Number of subjects: 161
Study: 21237383

Group type: EXPERIMENTAL
Intervention: Prehospital ECG
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Prehospital ECG (Male)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Prehospital ECG (Female)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Prehospital ECG (Overall)
Number of subjects: 425
Study: 18936284

Group type: EXPERIMENTAL
Intervention: Taranabant 6 mg/day
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 17540797

Group type: EXPERIMENTAL
Intervention: Quick Start (immediate, directly observed ingestion of the first pill during the clinic visit)
Number of subjects: 1716

Group type: COMPARATOR
Intervention: Conventional Start (waiting until menses to start the oral contraceptive pill)
Number of subjects: 1716

Group type: EXPERIMENTAL
Intervention: Quick Start
Number of subjects: 1716

Group type: COMPARATOR
Intervention: Quick Start and Conventional Start
Number of subjects: 1716
Study: 15467969

Group type: EXPERIMENTAL
Intervention: Antidepressive treatment for 35 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Long-term follow-up (> 12 months)
Number of subjects: 24
Study: 11179527

Group type: EXPERIMENTAL
Intervention: Single-dose of amiodarone (three 200-mg Cordarone tablets) after an overnight fast
Number of subjects: 30

Group type: COMPARATOR
Intervention: Single-dose of amiodarone (three 200-mg Cordarone tablets) after a standard high-fat breakfast
Number of subjects: 30
Study: 9530364

Group type: COMPARATOR
Intervention: Granisetron (40 micrograms/kg) infused for 30 minutes before CDDP infusion (standard method)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Granisetron mixed with CDDP and infused over 0.5-3 hours (simultaneous method)
Number of subjects: 41
Study: 8017591

Group type: EXPERIMENTAL
Intervention: Low-dose propofol (0.3 microgram.ml‐1, 0.6 microgram.ml‐1, 0.9 microgram.ml‐1)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Low-dose propofol
Number of subjects: 28
Study: 2722727

Group type: EXPERIMENTAL
Intervention: Cefmetazole
Number of subjects: 128

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 128
Study: 31053896

Group type: EXPERIMENTAL
Intervention: Resin-based composite (Spectrum TPH3)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Compomer (Dyract Posterior)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: N2O inhalation sedation or general anesthesia
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Distal-occlusal compomer restorations
Number of subjects: 260
Study: 30428913

Group type: EXPERIMENTAL
Intervention: CASS system
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional sleeve
Number of subjects: 60
Study: 28025062

Group type: EXPERIMENTAL
Intervention: e-feedback after video observation of surgical suturing
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard verbal feedback after direct observation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Poststudy questionnaire for e-feedback
Number of subjects: 38

Group type: COMPARATOR
Intervention: Poststudy questionnaire for standard verbal feedback
Number of subjects: 38
Study: 26551748

Group type: EXPERIMENTAL
Intervention: Therapeutic riding
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-riding control group
Number of subjects: 26
Study: 23875838

Group type: EXPERIMENTAL
Intervention: Theatre-arts intervention taught by in-house activity directors with no formal training in theatre
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Theatre-arts intervention taught by a professional acting teacher with minimal training
Number of subjects: 115
Study: 21203878

Group type: EXPERIMENTAL
Intervention: 2% preservative-free 2-chloroprocaine 40 mg
Number of subjects: 106

Group type: COMPARATOR
Intervention: 0.75% hyperbaric bupivacaine 7.5 mg
Number of subjects: 106
Study: 18471639

Group type: EXPERIMENTAL
Intervention: 1 mL of gatifloxacin in the dilating mixture
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 1 mL of moxifloxacin in the dilating mixture
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 2 mL of gatifloxacin in the dilating mixture
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 2 mL of moxifloxacin in the dilating mixture
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups (gatifloxacin and moxifloxacin)
Number of subjects: 100
Study: 16841628

Group type: EXPERIMENTAL
Intervention: Interpersonal and Social Rhythm Therapy
Number of subjects: 174

Group type: COMPARATOR
Intervention: Intensive clinical management approach
Number of subjects: 174
Study: 14623834

Group type: EXPERIMENTAL
Intervention: 25 mg oral dexketoprofen trometamol
Number of subjects: 122

Group type: COMPARATOR
Intervention: 50 mg sodium diclofenac
Number of subjects: 122
Study: 10934667

Group type: COMPARATOR
Intervention: Oseltamivir (20-1000 mg single dose or 50-500 mg bid for 7 days)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Oseltamivir (100-200 mg bid for 7 days)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 9059203

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES 200/0.5)
Number of subjects: 46

Group type: COMPARATOR
Intervention: 3% modified fluid gelatin (MFG)
Number of subjects: 46
Study: 8442438

Group type: EXPERIMENTAL
Intervention: Intermittent, cyclic etidronate (400 mg/day for 2 weeks followed by 13 weeks free from study drug administration)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intermittent, cyclic etidronate
Number of subjects: 66
Study: 3801827

Group type: EXPERIMENTAL
Intervention: Local instillation of fibrin adhesive (Beriplast)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No special treatment post-operatively (Control)
Number of subjects: 30
Study: 30880938

Group type: EXPERIMENTAL
Intervention: Aclidinium/formoterol 400/12 µg
Number of subjects: 3394
Study: 28918877

Group type: EXPERIMENTAL
Intervention: Raltegravir 1200 mg once daily with tenofovir disoproxil fumarate and emtricitabine
Number of subjects: 802

Group type: COMPARATOR
Intervention: Raltegravir 400 mg twice daily with tenofovir disoproxil fumarate and emtricitabine
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Raltegravir 1200 mg once daily
Number of subjects: 802

Group type: COMPARATOR
Intervention: Raltegravir 400 mg twice daily
Number of subjects: 802
Study: 26351350

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 815

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Peptide Vaccination (PV)
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: GM-CSF with resected visceral metastases
Number of subjects: 815
Study: 23061402

Group type: EXPERIMENTAL
Intervention: Hybrid cycle training (hand cycling combined with functional electrical stimulation-induced leg cycling)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hand cycle training (control group)
Number of subjects: 40
Study: 21943352

Group type: EXPERIMENTAL
Intervention: Novel milk protein peptide (MP) mixture
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 19782784

Group type: EXPERIMENTAL
Intervention: Formal exercise program in addition to optimal medical therapy
Number of subjects: 2331

Group type: COMPARATOR
Intervention: Optimal medical therapy alone without any formal exercise training
Number of subjects: 2331
Study: 17716260

Group type: EXPERIMENTAL
Intervention: Before sintering
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: After sintering
Number of subjects: 10

Group type: COMPARATOR
Intervention: Before/After sintering
Number of subjects: 10
Study: 12923144

Group type: EXPERIMENTAL
Intervention: Hyaluronate-containing product (SpermCatch)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PVP-containing product (ICSI-100)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (sperm maintenance medium)
Number of subjects: 0
Study: 10632686

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg twice daily started the morning before the procedure
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg twice daily started the morning of the procedure
Number of subjects: 84
Study: 8862639

Group type: EXPERIMENTAL
Intervention: Dopexamine 2 micrograms.kg‐1.min‐1
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Dopexamine 6 micrograms.kg‐1.min‐1
Number of subjects: 7
Study: 1340938

Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 6359471

Group type: EXPERIMENTAL
Intervention: Calcitonin treatment for four weeks
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Calcitonin treatment for over one year
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Calcitonin treatment after discontinuation
Number of subjects: 41
Study: 4011138

Group type: EXPERIMENTAL
Intervention: Hypotonic saline solution (150 mOsm/L)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hypotonic saline solutions (75-225 mOsm/L)
Number of subjects: 20
Study: 29058022

Group type: EXPERIMENTAL
Intervention: Injury-prevention programme (neuromuscular exercises) for one season
Number of subjects: 279

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 279
Study: 27179720

Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 5380

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5380
Study: 24502822

Group type: EXPERIMENTAL
Intervention: 18-month care coordination intervention
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 303